RN Nursing · Medications Affecting the Immune System
Antitubercular Drugs: RIPE Therapy for Tuberculosis
A focused review of the four first-line antitubercular medications (rifampin, isoniazid, pyrazinamide, ethambutol), their mechanisms, key toxicities, monitoring, and nursing priorities.
On this page
Tuberculosis (TB) is treated with a combination of medications collectively remembered as RIPE therapy. This note reviews the four first-line antitubercular drugs, their hallmark toxicities, required monitoring, and the nursing priorities most often tested on the NCLEX.
Drug Identification Table
- Isoniazid (INH) — First-line TB treatment. Exam clue: peripheral neuropathy risk.
- Rifampin — TB and other infections. Exam clue: orange body fluids.
- Pyrazinamide — Active TB treatment. Exam clue: hepatotoxicity risk.
- Ethambutol — Combination TB therapy. Exam clue: vision toxicity.
Mnemonic — RIPE therapy:
- R = Rifampin
- I = Isoniazid
- P = Pyrazinamide
- E = Ethambutol
Mechanism of Action
- Antitubercular drugs inhibit the growth or survival of Mycobacterium tuberculosis.
- Each drug targets a different step of bacterial metabolism or cell wall synthesis.
- Combination therapy is used to prevent drug resistance.
Treatment Principles
- TB treatment always requires multiple medications at the same time.
- Therapy usually lasts 6 months or longer.
- Directly observed therapy (DOT) is often used to ensure adherence.
Indications
Antitubercular drugs are used to treat:
- Active tuberculosis infection
- Latent tuberculosis infection
- Drug-resistant tuberculosis (with modified regimens)
Isoniazid is commonly used for latent TB infection.
Side Effects
Each drug has a characteristic toxicity that is commonly tested:
- Hepatotoxicity — isoniazid, rifampin, pyrazinamide
- Peripheral neuropathy — isoniazid (due to vitamin B6 deficiency)
- Orange body fluids — rifampin
- Optic neuritis and vision changes — ethambutol
Labs and Monitoring
- Monitor liver function tests (AST, ALT) because several drugs are hepatotoxic.
- Perform visual acuity testing for patients receiving ethambutol.
- Monitor for symptoms of peripheral neuropathy.
Contraindications and Cautions
Use antitubercular drugs cautiously in patients with:
- Severe liver disease
- History of optic neuritis (ethambutol)
- Pre-existing peripheral neuropathy
Drug interactions are common with rifampin.
Pregnancy Safety
- Some antitubercular drugs may be used during pregnancy when necessary.
- Isoniazid is commonly used with vitamin B6 (pyridoxine) supplementation.
- Treatment decisions should balance maternal benefit against fetal risk.
Nursing Safety Rules & High-Yield NCLEX Traps
- Give vitamin B6 (pyridoxine) with isoniazid to prevent peripheral neuropathy.
- Teach patients on rifampin that body fluids (urine, sweat, tears) can turn orange — and may stain contact lenses and clothing.
- Patients on ethambutol should report vision changes immediately.
- Patients must complete the entire course of therapy to prevent drug resistance.
- Common NCLEX traps: missing early signs of hepatotoxicity, ignoring vision changes, and poor medication adherence.
Key takeaways
- RIPE therapy = Rifampin, Isoniazid, Pyrazinamide, Ethambutol — used together to prevent resistance.
- Treatment lasts 6 months or longer, often with DOT.
- Major adverse effects: hepatotoxicity (INH, rifampin, pyrazinamide), peripheral neuropathy (INH), orange body fluids (rifampin), and optic neuritis (ethambutol).
- Always give vitamin B6 with isoniazid to prevent neuropathy.
- Monitor LFTs routinely and visual acuity with ethambutol; report vision changes immediately.
Test yourself on Antitubercular Medications
144 practice questions, each with a full teaching rationale.
Practise free